{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T15:18:12Z","timestamp":1785338292136,"version":"3.55.0"},"reference-count":42,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,8,16]],"date-time":"2024-08-16T00:00:00Z","timestamp":1723766400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Kawasaki disease (KD) is characterized as an acute febrile inflammatory disorder, which may potentially escalate into a more severe condition termed Kawasaki disease shock syndrome (KDSS). The objective of this research is to understand the clinical attributes of KDSS and to explore the predictive significance of coagulation profiles in the incidence of KDSS.<\/jats:p><\/jats:sec><jats:sec><jats:title>Method<\/jats:title><jats:p>Patients with Kawasaki disease (KD) were prospectively enrolled and divided into the KDSS group (<jats:italic>n<\/jats:italic>\u2009=\u200929) and the non-KDSS group (<jats:italic>n<\/jats:italic>\u2009=\u2009494). Multivariate logistic regression analysis was used to ascertain the relationship between coagulation profiles and KDSS. Furthermore, ROC curve analysis was conducted to evaluate the predictive value of the coagulation profile for the occurrence of KDSS.<\/jats:p><\/jats:sec><jats:sec><jats:title>Result<\/jats:title><jats:p>Among the KDSS patients, the median age was higher and cervical lymph node involvement was greater compared to the non-KDSS group. Additionally pericardial effusion, valve regurgitation, cardiac enlargement, coronary artery lesions (CALs), and Intravenous immunoglobulin (IVIG) resistance were significantly more frequent in the KDSS group than in non-KDSS group. Notably, Prothrombin time (PT), activated partial thromboplastin time (APTT), D-dimer, and fibrin degradation products (FDP) were significantly elevated in the KDSS group compared to the non-KDSS group. Conversely, total thrombin time (TT), fibrinogen, and antithrombin III (ATIII) activity were significantly reduced. Multivariate logistic regression analysis revealed that PT, APTT, D-dimer, and ATIII were independent risk factors for predicting KDSS occurrence. ROC curve analysis established critical values for PT, D-dimer, FDP, and ATIII as 13.45\u2005s, 2.03\u2005mg\/L, 7.45\u2005\u03bcg\/ml, and 77.5%, respectively. Sensitivity for predicting KDSS occurrence was 76%, 79%, 83%, and 76%, while specificity was 51%, 72%, 63%, and 80%, respectively. When we performed a combined ROC curve analysis of the four indicators, we found that its predictive sensitivity was much higher. Moreover, the Delong test results showed that the AUC of the combined analysis was significantly higher than that of the individual analyses.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Characteristic features of KDSS include older age, a greater likelihood of experiencing pericardial effusion, valve regurgitation, cardiac enlargement, CALs, and IVIG resistance. KD patients with a hypercoagulable state during the acute phase are at a higher risk of developing KDSS.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fped.2024.1450710","type":"journal-article","created":{"date-parts":[[2024,8,16]],"date-time":"2024-08-16T04:45:14Z","timestamp":1723783514000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Predictive value of coagulation profiles for Kawasaki disease shock syndrome: a prospective cohort study"],"prefix":"10.3389","volume":"12","author":[{"given":"Bowen","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoliang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuran","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yimin","family":"Hua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyu","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaiyu","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,8,16]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"e927","DOI":"10.1161\/CIR.0000000000000484","article-title":"Diagnosis, treatment, and long-term management of Kawasaki disease: a scientific statement for health professionals from the American Heart Association","volume":"135","author":"McCrindle","year":"2017","journal-title":"Circulation"},{"key":"B2","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/BF00795375","article-title":"Atypical presentation of Kawasaki disease in an infant","volume":"14","author":"Gamillscheg","year":"1993","journal-title":"Pediatr Cardiol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1097\/00006454-199612000-00021","article-title":"Simultaneous presentation of Kawasaki disease and toxic shock syndrome in an adolescent male","volume":"15","author":"Davies","year":"1996","journal-title":"Pediatr Infect Dis J"},{"key":"B4","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1111\/j.1442-200X.1994.tb03220.x","article-title":"Acute heart failure and acute renal failure in Kawasaki disease","volume":"36","author":"Senzaki","year":"1994","journal-title":"Acta Paediatr Jpn"},{"key":"B5","doi-asserted-by":"publisher","first-page":"e786","DOI":"10.1542\/peds.2008-1275","article-title":"Kawasaki disease in a pediatric intensive care unit: a case-control study","volume":"122","author":"Dominguez","year":"2008","journal-title":"Pediatrics"},{"key":"B6","doi-asserted-by":"publisher","first-page":"e783","DOI":"10.1542\/peds.2008-1871","article-title":"Recognition of a Kawasaki disease shock syndrome","volume":"123","author":"Kanegaye","year":"2009","journal-title":"Pediatrics"},{"key":"B7","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1007\/s00431-012-1879-1","article-title":"Clinical manifestations associated with Kawasaki disease shock syndrome in Mexican children","volume":"172","author":"Gamez-Gonzalez","year":"2013","journal-title":"Eur J Pediatr"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1097\/INF.0b013e31829efae6","article-title":"Population-based study of Kawasaki disease shock syndrome in Taiwan","volume":"32","author":"Lin","year":"2013","journal-title":"Pediatr Infect Dis J"},{"key":"B9","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.jmii.2013.06.005","article-title":"Clinical manifestations of Kawasaki disease shock syndrome: a case-control study","volume":"48","author":"Chen","year":"2015","journal-title":"J Microbiol Immunol Infect"},{"key":"B10","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1177\/0009922817729483","article-title":"Clinical manifestations of Kawasaki disease shock syndrome","volume":"57","author":"Ma","year":"2018","journal-title":"Clin Pediatr"},{"key":"B11","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1253\/circj.CJ-11-0928","article-title":"A halfcentury of autopsy results\u2013incidence of pediatric vasculitis syndromes, especially Kawasaki disease","volume":"76","author":"Takahashi","year":"2012","journal-title":"Circ J"},{"key":"B12","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/s10067-016-3316-8","article-title":"Describing Kawasaki shock syndrome: results from a retrospective study and literature review","volume":"36","author":"Taddio","year":"2017","journal-title":"Clin Rheumatol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12969-018-0303-4","article-title":"Kawasaki disease shock syndrome: clinical characteristics and possible use of IL-6, IL-10 and IFN-\u03b3as biomarkers for early recognition","volume":"17","author":"Li","year":"2019","journal-title":"Pediatr Rheumatol Online J"},{"key":"B14","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1046\/j.1365-2362.1997.570614.x","article-title":"The cytokinemediated imbalance between coagulant and anticoagulant mechanisms in sepsis and endotoxaemia","volume":"27","author":"Levi","year":"1997","journal-title":"Eur J Clin Invest"},{"key":"B15","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s40560-018-0322-8","article-title":"Treatment of patients with sepsis in a closed intensive care unit is associated with improved survival: a nationwide observational study in Japan","volume":"6","author":"Ogura","year":"2018","journal-title":"J Intensive Care"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1111\/pai.13495","article-title":"Predictive value of coagulation profiles for both initial and repeated immunoglobulin resistance in Kawasaki disease: a prospective cohort study","volume":"32","author":"Shao","year":"2021","journal-title":"Pediatr Allergy Immunol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1159\/000368402","article-title":"Persistent endothelial damage after intravenous immunoglobulin therapy in Kawasaki disease","volume":"165","author":"Sakurai","year":"2014","journal-title":"Inter Arch Allergy Immunol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1007\/s12519-019-00234-6","article-title":"Biomarkers of intravenous immunoglobulin resistance and coronary artery lesions in Kawasaki disease","volume":"15","author":"Kong","year":"2019","journal-title":"World J Pediatr"},{"key":"B19","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1111\/1744-9987.12235","article-title":"Elevated D-dimer level is a risk factor for coronary artery lesions accompanying intravenous immunoglobulin-unresponsive Kawasaki disease","volume":"19","author":"Masuzawa","year":"2015","journal-title":"Therap Apheresis Dia"},{"key":"B20","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1177\/107602960100700306","article-title":"Low tissue plasminogen activator relative to plasminogen activator inhibitor-1 as a marker of cardiac complication in children with Kawasaki disease","volume":"7","author":"Sakai","year":"2001","journal-title":"Clin Appl Throm"},{"key":"B21","doi-asserted-by":"publisher","first-page":"5121","DOI":"10.26355\/eurrev_201808_15706","article-title":"Correlations of complication with coronary arterial lesion with VEGF, PLT, D-dimer and inflammatory factor in child patients with Kawasaki disease","volume":"22","author":"Zhou","year":"2018","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"B22","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1007\/s00431-005-1699-7","article-title":"Impact of increased D-dimer concentrations in Kawasaki disease","volume":"164","author":"Imamura","year":"2005","journal-title":"Eur J Pediatr"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1542\/peds.2004-2182","article-title":"Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the committee on rheumatic fever, endocarditis, and Kawasaki disease, council on cardiovascular disease in the young, American Heart Association","volume":"114","author":"Newburger","year":"2004","journal-title":"Pediatrics"},{"key":"B24","first-page":"20","article-title":"Pediatric assessment","volume-title":"APLS: The Pediatric Emergency Medicine Resource","author":"Dieckmann","year":"2007"},{"key":"B25","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1097\/01.PCC.0000257039.32593.DC","article-title":"Analysis of the evidence for the lower limit of systolic and mean arterial pressure in children","volume":"8","author":"Haque","year":"2007","journal-title":"Pediatr Crit Care Med"},{"key":"B26","first-page":"106","article-title":"Cardiovascular system","volume-title":"APLS: The Pediatricemergency Medicine Resource","author":"Fitzmaurice","year":"2007"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10067-016-3316-8","article-title":"Describing Kawasaki shock syndrome: results from a retrospective study and literature review","volume":"36","author":"Taddio","year":"2016","journal-title":"Clin Rheumatol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1017\/S1047951111001314","article-title":"Capillary leak leading to shock in Kawasaki disease without myocardial dysfunction","volume":"22","author":"Natterer","year":"2012","journal-title":"Cardiol Young"},{"key":"B29","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1007\/s10875-012-9668-1","article-title":"Inflammation-induced hepcidin is associated with the development of anemia and coronary artery lesions in Kawasaki disease","volume":"32","author":"Kuo","year":"2012","journal-title":"J Clin Immunol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1161\/01.CIR.0000151311.38708.29","article-title":"Elevated levels of high-sensitivity C-reactive protein and serum amyloid-a late after Kawasaki disease: association between inflammation and late coronary sequelae in Kawasaki disease","volume":"111","author":"Mitani","year":"2005","journal-title":"Circulation"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1016\/j.jhep.2016.02.004","article-title":"IL-6 Pathway in the liver: from physiopathology to therapy","volume":"64","author":"Schmidt-Arras","year":"2016","journal-title":"J Hepatol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1002\/jcp.1041650312","article-title":"Interferongamma and tumor necrosis factor-alpha suppress both early and late stages of hematopoiesis and induce programmed cell death","volume":"165","author":"Selleri","year":"1995","journal-title":"J Cell Physiol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"e276","DOI":"10.1016\/S1473-3099(20)30651-4","article-title":"COVID-19 and multisystem inflammatory syndrome in children and adolescents","volume":"20","author":"Jiang","year":"2020","journal-title":"Lancet Infect Dis"},{"key":"B34","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1056\/NEJMra1011170","article-title":"The coagulopathy of chronic liver disease","volume":"365","author":"Tripodi","year":"2011","journal-title":"N Engl J Med"},{"key":"B35","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1034\/j.1600-0528.2002.017404.x","article-title":"The liver as a crucial organ in the first line of host defense: the roles of Kupffer cells, natural killer (NK) cells and NK1.1 Ag+ T cells in T helper 1 immune responses","volume":"174","author":"Seki","year":"2000","journal-title":"Immunol Rev"},{"key":"B36","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1002\/JLB.4COVR0920-552RR","article-title":"Identification of key signaling pathways induced by SARS-CoV2 that underlie thrombosis and vascular injury in COVID-19 patients","volume":"109","author":"Maxwell","year":"2021","journal-title":"J Leukoc Biol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1038\/s41390-019-0668-1","article-title":"Shock and unresponsiveness to repeated courses of intravenous immunoglobulin in Kawasaki disease: a nationwide database study","volume":"87","author":"Liang","year":"2020","journal-title":"Pediatr Res"},{"key":"B38","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1179\/2046905515Y.0000000002","article-title":"Kawasaki disease shock syndrome: case report","volume":"36","author":"Yang","year":"2016","journal-title":"Paediatr Int Child Health"},{"key":"B39","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1016\/j.cjca.2021.05.014","article-title":"Kawasaki disease shock syndrome vs classical Kawasaki disease: a meta-analysis and comparison with SARS-CoV-2 multisystem inflammatory syndrome","volume":"37","author":"Lamrani","year":"2021","journal-title":"Can J Cardiol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1093\/jpids\/piw081","article-title":"Hyponatremia is a feature of Kawasaki disease shock syndrome: a case-control study","volume":"6","author":"Schuster","year":"2017","journal-title":"J Pediatric Infect Dis Soc"},{"key":"B41","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1097\/INF.0000000000000852","article-title":"Early differentiation of Kawasaki disease shock syndrome and toxic shock syndrome in a pediatric intensive care unit","volume":"34","author":"Lin","year":"2015","journal-title":"Pediatr Infect Dis J"},{"key":"B42","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1017\/S1047951118002056","article-title":"Association between left ventricular ejection fraction and Kawasaki disease shock syndrome","volume":"29","author":"Qiu","year":"2019","journal-title":"Cardiol Young"}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2024.1450710\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,16]],"date-time":"2024-08-16T04:45:18Z","timestamp":1723783518000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2024.1450710\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,16]]},"references-count":42,"alternative-id":["10.3389\/fped.2024.1450710"],"URL":"https:\/\/doi.org\/10.3389\/fped.2024.1450710","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,16]]},"article-number":"1450710"}}